Address
Amstelkade 39A
3652 ME Woerdense Verlaat
The Netherlands
The Netherlands
Contact
Leonie de Best+31610961454
leonie.debest@madam-therapeutics.com
Website
Novel antimicrobial peptides
Madam Therapeutics is developing novel antibiotics to fight antimicrobial resistance
Very effective and safe antimicrobial peptides identified using Artificial intelligence.
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- Environmental
- Other
- AgriFood
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Prefferably investor or codevelopment/lisence partner with infectious diseases expertise or background
Madam Therapeutics is an innovative biotech company that develops novel antimicrobial therapies to fight antimicrobial resistance (AMR).
They have a very rapid killing effect by disrupting their cell membrane. Broad spectrum, also against multidrug and PAN drug resistant bacteria
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!